EcoR1 Capital as of Dec. 31, 2022
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 66 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prothena Corp SHS (PRTA) | 21.2 | $698M | 12M | 60.25 | |
| Sarepta Therapeutics (SRPT) | 11.8 | $389M | 3.0M | 129.58 | |
| Apellis Pharmaceuticals (APLS) | 8.2 | $268M | 5.2M | 51.71 | |
| Anaptysbio Inc Common (ANAB) | 7.1 | $233M | 7.5M | 30.99 | |
| Galapagos Nv Spon Adr (GLPG) | 5.0 | $166M | 3.7M | 44.38 | |
| Xencor (XNCR) | 4.2 | $138M | 5.3M | 26.04 | |
| Arvinas Ord (ARVN) | 3.3 | $107M | 3.1M | 34.21 | |
| Revolution Medicines (RVMD) | 3.2 | $106M | 4.5M | 23.82 | |
| Morphic Hldg (MORF) | 3.2 | $106M | 4.0M | 26.75 | |
| ACADIA Pharmaceuticals (ACAD) | 2.9 | $95M | 6.0M | 15.92 | |
| Springworks Therapeutics (SWTX) | 2.7 | $90M | 3.5M | 26.01 | |
| Kura Oncology (KURA) | 2.5 | $82M | 6.6M | 12.41 | |
| Zai Lab Adr (ZLAB) | 2.0 | $66M | 2.2M | 30.70 | |
| Relay Therapeutics (RLAY) | 1.9 | $62M | 4.2M | 14.94 | |
| Zymeworks Del Com Added (ZYME) | 1.8 | $60M | 7.6M | 7.86 | |
| Alector (ALEC) | 1.1 | $37M | 4.1M | 9.23 | |
| Ngm Biopharmaceuticals | 1.0 | $32M | 6.4M | 5.02 | |
| Adicet Bio (ACET) | 1.0 | $32M | 3.6M | 8.94 | |
| Edgewise Therapeutics (EWTX) | 1.0 | $31M | 3.5M | 8.94 | |
| Tango Therapeutics (TNGX) | 0.9 | $31M | 4.2M | 7.25 | |
| Atea Pharmaceuticals (AVIR) | 0.9 | $30M | 6.2M | 4.81 | |
| Voyager Therapeutics (VYGR) | 0.9 | $29M | 4.8M | 6.10 | |
| Allogene Therapeutics (ALLO) | 0.9 | $28M | 4.5M | 6.29 | |
| Dyne Therapeutics (DYN) | 0.8 | $27M | 2.3M | 11.59 | |
| Nuvation Bio Com Cl A (NUVB) | 0.8 | $27M | 14M | 1.92 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.7 | $24M | 1.3M | 18.30 | |
| Oric Pharmaceuticals (ORIC) | 0.6 | $20M | 3.4M | 5.89 | |
| Kymera Therapeutics (KYMR) | 0.6 | $20M | 796k | 24.96 | |
| Graphite Bio | 0.6 | $19M | 5.7M | 3.32 | |
| Janux Therapeutics (JANX) | 0.6 | $19M | 1.4M | 13.17 | |
| Chinook Therapeutics | 0.6 | $18M | 690k | 26.20 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.5 | $16M | 5.2M | 3.10 | |
| Poseida Therapeutics I (PSTX) | 0.4 | $14M | 2.7M | 5.30 | |
| Ventyx Biosciences (VTYX) | 0.4 | $13M | 400k | 32.79 | |
| Ovid Therapeutics (OVID) | 0.3 | $11M | 6.1M | 1.86 | |
| Prime Medicine Com Added (PRME) | 0.3 | $11M | 600k | 18.58 | |
| Cullinan Oncology (CGEM) | 0.3 | $11M | 1.0M | 10.55 | |
| 2seventy Bio Common Stock | 0.3 | $11M | 1.1M | 9.37 | |
| Geron Corporation (GERN) | 0.3 | $9.7M | 4.0M | 2.42 | |
| Aveo Pharmaceuticals Com New | 0.3 | $9.7M | 651k | 14.95 | |
| Bioatla (BCAB) | 0.3 | $9.3M | 1.1M | 8.25 | |
| Design Therapeutics (DSGN) | 0.3 | $9.1M | 885k | 10.26 | |
| Gracell Biotechnologies Sponsored Ads | 0.2 | $7.7M | 3.3M | 2.30 | |
| Macrogenics (MGNX) | 0.2 | $7.5M | 1.1M | 6.71 | |
| Immatics SHS (IMTX) | 0.2 | $6.5M | 743k | 8.71 | |
| Arcutis Biotherapeutics (ARQT) | 0.2 | $6.1M | 415k | 14.80 | |
| Precision Biosciences Ord | 0.2 | $6.0M | 5.0M | 1.19 | |
| Health Sciences Acq Corp 2 Ord Shs | 0.1 | $4.0M | 400k | 9.98 | |
| Selecta Biosciences | 0.1 | $4.0M | 3.5M | 1.13 | |
| Praxis Precision Medicines I | 0.1 | $3.8M | 1.6M | 2.38 | |
| Aligos Therapeutics | 0.1 | $3.8M | 3.9M | 0.95 | |
| Abeona Therapeutics Com New (ABEO) | 0.1 | $3.3M | 1.1M | 3.08 | |
| Surface Oncology | 0.1 | $3.2M | 3.9M | 0.82 | |
| Erasca (ERAS) | 0.1 | $2.9M | 678k | 4.31 | |
| Hookipa Pharma Inc equity | 0.1 | $2.0M | 2.5M | 0.81 | |
| Eucrates Biomedical Acqu Cor SHS | 0.1 | $2.0M | 200k | 9.99 | |
| Nuvation Bio *w Exp 07/07/202 (NUVB.WS) | 0.1 | $1.8M | 963k | 1.92 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.5M | 150k | 10.10 | |
| Tempest Therapeutics | 0.0 | $1.2M | 1.0M | 1.15 | |
| Iteos Therapeutics | 0.0 | $791k | 41k | 19.53 | |
| Newamsterdam Pharma Company *w Exp 11/22/202 Added (NAMSW) | 0.0 | $727k | 67k | 10.90 | |
| Eucrates Biomedical Acqu Cor *w Exp 10/23/202 | 0.0 | $666k | 67k | 9.99 | |
| Kronos Bio | 0.0 | $529k | 327k | 1.62 | |
| Black Diamond Therapeutics (BDTX) | 0.0 | $508k | 282k | 1.80 | |
| Caremax *w Exp 06/08/202 | 0.0 | $365k | 100k | 3.65 | |
| Surrozen *w Exp 08/01/203 (SRZNW) | 0.0 | $39k | 67k | 0.58 |
